Summary of patient samples xenotransplanted in NSG immunodeficient animals
| Patient | Age | Gender | Sample | % of blasts | Karyotype | Engraftment | Mean % |
| AMKL1 | 6 mo | F | Fresh | 20 | 46,XX, t(1;22)(p13;q13) [17]/46, idem, ider(11) add(11)(p14) t(11;12)(q11;q23) [2]/46,XX [1] | 2/4 | 89.7 |
| AMKL2 | 21 mo | M | Frozen | 55 | 55, XY, +6, +9, t(9;11)(p22;q23), +10, +13, +19, +20, +21, +22, +22 [18] / 46, XY [2] | 1/3 | 42.7 |
| AMKL3 | 53 yr | M | Fresh | 70 | ND | 0/4 | NA |
| AMKL4 | 15 mo | M | Frozen | 20 | 51-52 XY, t(2;7)(q23;q21), t(2;11)(p11;p11-12), +4, +6, +8, +9, +/− 10, del(13)(q12-q13.14), +21 [17]/ 52-53, idem, + 13 [2]/ 46, XY [1] | 4/4 | 60.7 |
| AMKL4R | 26 mo | M | Fresh | 75 | ND | 3/3 | 32.3 |
| AMKL5 | 70 yr | F | Frozen | 80 | ND | 0/4 | NA |
| AMKL6 | 72 yr | M | Fresh | 87 | ND | 1/4 | 16 |
| AMKL7 | 42 mo | M | Frozen | 80 | ND | 2/5 | 66.6 |
| Patient | Age | Gender | Sample | % of blasts | Karyotype | Engraftment | Mean % |
| AMKL1 | 6 mo | F | Fresh | 20 | 46,XX, t(1;22)(p13;q13) [17]/46, idem, ider(11) add(11)(p14) t(11;12)(q11;q23) [2]/46,XX [1] | 2/4 | 89.7 |
| AMKL2 | 21 mo | M | Frozen | 55 | 55, XY, +6, +9, t(9;11)(p22;q23), +10, +13, +19, +20, +21, +22, +22 [18] / 46, XY [2] | 1/3 | 42.7 |
| AMKL3 | 53 yr | M | Fresh | 70 | ND | 0/4 | NA |
| AMKL4 | 15 mo | M | Frozen | 20 | 51-52 XY, t(2;7)(q23;q21), t(2;11)(p11;p11-12), +4, +6, +8, +9, +/− 10, del(13)(q12-q13.14), +21 [17]/ 52-53, idem, + 13 [2]/ 46, XY [1] | 4/4 | 60.7 |
| AMKL4R | 26 mo | M | Fresh | 75 | ND | 3/3 | 32.3 |
| AMKL5 | 70 yr | F | Frozen | 80 | ND | 0/4 | NA |
| AMKL6 | 72 yr | M | Fresh | 87 | ND | 1/4 | 16 |
| AMKL7 | 42 mo | M | Frozen | 80 | ND | 2/5 | 66.6 |
F, female; M, male; NA, not applicable; R, relapse. Age at diagnosis is indicated in months or years. “Mean %” indicates the mean percentage of human cells.